Skip to main content
Log in

Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

This study aimed to assess whether standard-dose Betahistine (48 mg daily) exerts an effect upon the degree of endolymphatic hydrops in patients with Menière’s disease using a retrospective case series in the setting of a tertiary neurotology referral centre. In six patients with definite unilateral Menière’s disease, the degree of cochlear and vestibular endolymphatic hydrops was assessed before and after treatment with a standard dose of Betahistine (48 mg daily), using high-resolution 3 T MR imaging after intratympanic contrast medium application. The treatment duration was 3–7 months (mean 5 months), and the patients were followed-up for 6–29 months (mean 11 months). In the study cohort, the standard dose of Betahistine did not have an MR morphologically measurable beneficial effect on the degree of endolymphatic hydrops. The results indicated no effect of standard-dose Betahistine on endolymphatic hydrops found on high-resolution MR imaging. Possible explanations are: (1) insufficient dosage or duration of treatment with betahistine, (2) insufficient resolution of the MR imaging technique, and (3) insufficient length of follow-up. Further studies addressing these issues are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. (1995) Otolaryngol Head Neck Surg 113:181-185

    Google Scholar 

  2. Merchant SN, Adams JC, Nadol JB Jr (2005) Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26:74–81

    Article  PubMed  Google Scholar 

  3. Kim HH, Wiet RJ, Battista RA (2005) Trends in the diagnosis and the management of Meniere’s disease: results of a survey. Otolaryngol Head Neck Surg 132:722–726

    Article  PubMed  Google Scholar 

  4. Westhofen M (2009) Meniere’s disease: evidence and controversies. HNO 57:446–454

    Article  PubMed  CAS  Google Scholar 

  5. Smith WK, Sankar V, Pfleiderer AG (2005) A national survey amongst UK otolaryngologists regarding the treatment of Meniere’s disease. J Laryngol Otol 119:102–105

    PubMed  CAS  Google Scholar 

  6. Timmerman H (1991) Histamine agonists and antagonists. Acta Otolaryngol Suppl 479:5–11

    Article  PubMed  CAS  Google Scholar 

  7. Arrang JM, Devaux B, Chodkiewicz JP et al (1988) H3-receptors control histamine release in human brain. J Neurochem 51:105–108

    Article  PubMed  CAS  Google Scholar 

  8. Martinez DM (1972) The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol Suppl 305:29–47

    Article  PubMed  CAS  Google Scholar 

  9. James AL, Burton MJ (2001) Betahistine for Meniere’s disease or syndrome. Cochrane Database Syst Rev (1):CD001873

  10. Nakashima T, Naganawa S, Sugiura M et al (2007) Visualization of endolymphatic hydrops in patients with Meniere’s Disease. The Laryngoscope 117:415–420

    Article  PubMed  Google Scholar 

  11. Gurkov R, Flatz W, Louza J et al (2011) In vivo visualization of endolyphatic hydrops in patients with Meniere’s disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol 268:1743–1748

    Article  PubMed  Google Scholar 

  12. Louza J, Flatz W, Krause E, Gürkov R (2012) Short-term audiologic effect of intratympanic gadolinium contrast agent application in patients with Meniere’s disease. Am J Otolaryngol [Epub ahead of print]

  13. Suzuki H, Teranishi M, Naganawa S et al (2011) Contrast-enhanced MRI of the inner ear after intratympanic injection of meglumine gadopentetate or gadodiamide hydrate. Acta Otolaryngol 131:130–135

    Article  PubMed  CAS  Google Scholar 

  14. Kato M, Teranishi M, Katayama N et al (2011) Association between endolymphatic hydrops as revealed by magnetic resonance imaging and caloric response. Otol Neurotol 32:1480–1485

    Article  PubMed  Google Scholar 

  15. Hornibrook J, Coates M, Goh A et al (2012) Magnetic resonance imaging for Meniere’s disease: correlation with tone burst electrocochleography. J Laryngol Otol 126:136–141

    Article  PubMed  CAS  Google Scholar 

  16. Horii A, Osaki Y, Kitahara T et al (2011) Endolymphatic hydrops in Meniere’s disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness. Acta Otolaryngol 131:602–609

    Article  PubMed  Google Scholar 

  17. Fang ZM, Chen X, Gu X, Liu Y, Zhang R, Cao DR, He HG (2012) A new magnetic resonance imaging scoring system for perilymphatic space appearance after intratympanic gadolinium injection, and its clinical application. J Laryngol Otol 126(5):454–459

    Google Scholar 

  18. Laurikainen E, Miller JM, Nuttall AL et al (1998) The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol 255:119–123

    Article  PubMed  CAS  Google Scholar 

  19. Laurikainen E, Miller JF, Pyykko I (2000) Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl 544:5–7

    Article  PubMed  CAS  Google Scholar 

  20. Strupp M, Hupert D, Frenzel C (2008) Long-term prophylactic treatment of attacks of vertigo in Meniere’s disease–comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 128:520–524

    Article  PubMed  CAS  Google Scholar 

  21. Lezius F, Adrion C, Mansmann U et al (2011) High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Meniere’s disease: a case series. Eur Arch Otorhinolaryngol 268:1237–1240

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Federal German Ministry of Education and Research (Grant no. 01EO0901). The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Conflict of interest

None of the authors have a conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Gürkov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gürkov, R., Flatz, W., Keeser, D. et al. Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol 270, 1231–1235 (2013). https://doi.org/10.1007/s00405-012-2087-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-012-2087-3

Keywords

Navigation